Ajay Nirula
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Immunology top 1%
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology
Papers in
-
- SARS-CoV-2 and COVID-19 Research 18
- COVID-19 Clinical Research Studies 11
- Immunology 17
- Psoriasis: Treatment and Pathogenesis 12
- Co-authors
- Paul A. Klekotka (16 shared papers)Scott Glaser (1 shared paper)Susan L. Kalled (1 shared paper)Greg Kricorian (5 shared papers)Cassandra E. Milmont (5 shared papers)Kim Alexander Papp (4 shared papers)Maria Greenwald (3 shared papers)Jesse Roth (3 shared papers)
- Journals
- New England Journal of Medicine (5 papers)Journal of the American Academy of Dermatology (4 papers)Nature Communications (3 papers)Annals of the Rheumatic Diseases (3 papers)The Journal of Rheumatology (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Ajay Nirula
59 papers receiving 5.2k citations
Ajay Nirula's Hit Papers
Peers
Comparison fields: 5 of 111
- Infectious Diseases 2.2k
- Immunology 1.6k
- Rheumatology 566
- Dermatology 89
- Toxicology 38
Countries citing papers authored by Ajay Nirula
This map shows the geographic impact of Ajay Nirula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajay Nirula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajay Nirula more than expected).
Fields of papers citing papers by Ajay Nirula
This network shows the impact of papers produced by Ajay Nirula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajay Nirula. The network helps show where Ajay Nirula may publish in the future.
Co-authors
The 25 scholars most cited alongside Ajay Nirula, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 Hit paper breakdown → | 2020 | 1012 |
| 2 | Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis Hit paper breakdown → | 2015 | 711 |
| 3 | Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 Hit paper breakdown → | 2021 | 702 |
| 4 | 2016 | 408 | |
| 5 | Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis Hit paper breakdown → | 2014 | 335 |
| 6 | 2010 | 249 | |
| 7 | 2020 | 246 | |
| 8 | 2021 | 155 | |
| 9 | 2020 | 132 | |
| 10 | 2016 | 108 | |
| 11 | 2014 | 102 | |
| 12 | A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis Hit paper breakdown → | 2023 | 99 |
| 13 | 1989 | 82 | |
| 14 | 2015 | 64 | |
| 15 | 2021 | 57 | |
| 16 | 2004 | 55 | |
| 17 | 2014 | 51 | |
| 18 | 2019 | 51 | |
| 19 | 2014 | 45 | |
| 20 | 2022 | 45 |
About Ajay Nirula
Ajay Nirula is a scholar working on Infectious Diseases, Immunology, Rheumatology, Dermatology and Pharmacology, having authored 61 papers that have together received 5.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (18 papers), Psoriasis: Treatment and Pathogenesis (12 papers), COVID-19 Clinical Research Studies (11 papers), Rheumatoid Arthritis Research and Therapies (7 papers), Dermatology and Skin Diseases (3 papers), Signaling Pathways in Disease (2 papers), Genomics and Chromatin Dynamics (2 papers) and Spondyloarthritis Studies and Treatments (2 papers). The work is most often cited by research in Infectious Diseases (2.2k citations), Immunology (1.6k citations), Rheumatology (566 citations), Dermatology (89 citations) and Toxicology (38 citations). Ajay Nirula has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Paul A. Klekotka, Scott Glaser, Susan L. Kalled, Greg Kricorian, Cassandra E. Milmont, Kim Alexander Papp, Maria Greenwald, Jesse Roth, Alan R. Shuldiner and Ngozi Erondu. Their work appears in journals such as New England Journal of Medicine, Journal of the American Academy of Dermatology, Nature Communications, Annals of the Rheumatic Diseases and The Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.